Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Cancer × Standard of Care × Clear all

Phase

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 10 Prostatic Neoplasms 7 Breast Neoplasms 7 Multiple Myeloma 6 Ovarian Neoplasms 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Recurrence 3 Neoplasms, Plasma Cell 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Neoplasms by Site 2 Mycoses 2 Medication Adherence 2 Lymphoma, Follicular 2 Leukemia 2 Hematologic Neoplasms 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 COVID-19 2 Adenocarcinoma 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1

Interventions

Nivolumab 14 Ipilimumab 6 linrodostat 5 relatlimab 3 Pemetrexed 3 Paclitaxel 3 Docetaxel 3 Carboplatin 3 ARRY-334543 3 regorafenib 2 abemaciclib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Gemcitabine 2 Capecitabine 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 trametinib 1 tislelizumab 1 sargramostim 1 ralimetinib 1 prexasertib 1 palifosfamide lysine 1 p38 Mitogen-Activated Protein Kinases 1 lirilumab 1 fluzoparib 1 fluorapacin 1 figitumumab 1 etirinotecan pegol 1 emibetuzumab 1 efatutazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04467593 2025-08-05

MATTERS

ElmediX

Phase NA Completed

Gastrointestinal

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡